Pharma Journalist -

Forge Therapeutics, Inc. (Forge) announced that they have entered into a research collaboration and option agreement with Hoffmann-La Roche Ltd. (Roche) to license FG-LpxC LUNG, a novel…
Read More...

Grifols announces that it has entered into a formal collaboration with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration…
Read More...

Debiopharm announced having entered into a worldwide, exclusive license & research agreement with 3B Pharmaceuticals (3BP), a German biotechnology firm, to further the development…
Read More...

Xencor, Inc. announced that it has entered into a technology license agreement with Vir Biotechnology, Inc., in which Vir will have non-exclusive access to Xencor’s Xtend Fc technology…
Read More...

Infinity Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for IPI-549 in combination with nivolumab (Opdivo) for the…
Read More...

SMi Reports: Krystin Meidell, Manager Regulatory Affairs CMc Medical Devices and Combination Products, Biogen Idec is interviewed for the Pre-filled Syringes East Coast 2020 conference…
Read More...

Alvotech Hf and DKSH, a leading healthcare provider across 36 emerging countries in South-East Asia, announced that Alvotech Hf and DKSH have entered into an exclusive license…
Read More...

CytomX Therapeutics, Inc. and Astellas Pharma Inc. announced that they have entered into a strategic collaboration agreement focused on the discovery, research, development and…
Read More...

Novavax, Inc. announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate with its…
Read More...

SMi Reports: Superbugs & Superdrugs conference taking place next week, will now be by remote access only With only 1 week remaining, the 22nd Annual Superbugs & Superdrugs…
Read More...